title: Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis.
abstract: Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hallmark of CL is skin ulcers likely driven by efforts of the immune system to control Leishmania growth. Cytokines, such as tumor necrosis factor (TNF) and interferon-gamma can control disease progression in animal models. Nevertheless, the impact of these cytokines in CL ulcer outcome is not well established in humans. In this study, 96 CL patients from an endemic area of Leishmania braziliensis were enrolled for a follow-up study that consisted of clinical and immunological evaluations in a 2-year period. Statistical analysis revealed that healing time (P = 0.029), age (P = 0.002), and TNF levels (P = 0.0002) positively correlate with ulcer size at the time of the first clinical evaluation. Our findings suggest that ulcer size correlates with healing time and TNF levels support the use of TNF inhibitors combined with standard therapy to improve healing in CL patients with severe lesions.
authors: Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. deepbahia@gmail.com
authors: Fabiano
authors: F
authors: Oliveira
authors: Andre
authors: A
authors: Bafica
authors: Andrea B
authors: AB
authors: Rosato
authors: Cecilia B F
authors: CB
authors: Favali
authors: Jackson M
authors: JM
authors: Costa
authors: Virginia
authors: V
authors: Cafe
authors: Manoel
authors: M
authors: Barral-Netto
authors: Aldina
authors: A
authors: Barral
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000953:Antigens, Protozoan / Q000276:immunology*; D005260:Female; D006801:Humans; D007891:Leishmania / Q000276:immunology*; D016773:Leishmaniasis, Cutaneous / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D000953:Antigens, Protozoan; D014409:Tumor Necrosis Factor-alpha